180.01
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
HSBC Adjusts Price Target on IQVIA to $210 From $240, Maintains Buy Rating - marketscreener.com
IQVIA unit announces senior notes offering - MSN
IQVIA Holdings (IQV) Plans €950M Senior Notes Offering for Debt Refinancing - GuruFocus
IQVIA plans €950 million senior notes offering due 2033 - Investing.com UK
IQVIA to Raise $1.10 Billion in Debt Offering - marketscreener.com
Inside IQVIA’s €950M notes plan to refinance existing debt - Stock Titan
IQVIA Announces Offering of Senior Notes - lincolnjournal.com
Is IQVIA Holdings Inc (IQV) a Bargain After 3.3% Drop? GF Value Says Undervalued - GuruFocus
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA Holdings earnings preview: What to expect - MSN
Here's why IQVIA Holdings (IQV) is a strong value stock - MSN
IQVIA Holdings, Inc. (IQV) Stock Analysis: A 25% Upside Potential Amid Strong Analyst Ratings - DirectorsTalk Interviews
Are Wall Street analysts predicting IQVIA Holdings stock will climb or sink? - MSN
Is It Too Late To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)? - Yahoo Finance
CNIL fines IQVIA €5M for health data warehouse breaches - PPC Land
IQVIA Holdings Hits Day High with 9.34% Surge in Strong Intraday Performance - Markets Mojo
Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise? - TradingView
IQVIA Holdings Inc stock (US46266C1053): shares advance after recent outlook hike and buyback suppor - AD HOC NEWS
IQVIA Holdings Inc (IQV) Stock Up 9.3% and Still Undervalued -- GF Score: 84/100 - GuruFocus
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA Rose 6% This Week. Here’s How Much the Stock Could Rise in 2026 - TIKR.com
IQVIA Jumps 9.3% as Investors Refocus on Raised 2026 Profit Outlook and Buyback Support - Moomoo
IQVIA jumps 9.3% as investors refocus on raised 2026 profit outlook and buyback support - Quiver Quantitative
IQVIA Holdings Jumps 5.7% Amid Sector-Wide Rally - AlphaStreet
Here's Why Investors Must Hold IQV Stock in Their Portfolios for Now - TradingView
Analysts Are Bullish on Top Healthcare Stocks: IQVIA Holdings (IQV), Lantheus (LNTH) - The Globe and Mail
IQVIA CEO to Speak at Jefferies Global Healthcare Conference 2026 - BioSpace
IQVIA Holdings Inc (IQV) Stock Down 3.5% -- Now Undervalued? GF Score: 86/100 - GuruFocus
IQVIA CEO to Speak at Jefferies Global Healthcare Conference - pharmiweb.com
JPMorgan Mid Cap Equity Fund's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term - Yahoo Finance
What Makes IQVIA Holdings (IQV) an Investment Bet? - Insider Monkey
IQVIA Holdings, Inc. (IQV): Analyst Consensus Reveals 36% Upside Potential for Healthcare Giant - DirectorsTalk Interviews
Liquidity Mapping Around (IQV) Price Events - Stock Traders Daily
IQVIA signals raised 2026 adjusted EPS outlook to $12.65-$12.95 while reaffirming $17.150B-$17.350B revenue - MSN
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Beta Bionics, Inc. (BBNX) and Twist Bioscience (TWST) - The Globe and Mail
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IQVIA Holdings Inc stock (US46266C1053): data-driven healthcare group in focus after latest earnings - AD HOC NEWS
Are Wall Street Analysts Predicting IQVIA Holdings Stock Will Climb or Sink? - Barchart.com
IQVIA’s SWOT analysis: healthcare stock faces margin pressures - Investing.com
IQVIA: The Market May Be Missing The AI And Data Story (NYSE:IQV) - Seeking Alpha
Research Alert: CFRA Moderates Rating On Shares Of Iqvia Holdings Inc. To Hold From Buy - Moomoo
IQVIA Holdings stock (US46266C1053): latest earnings highlight data strength and AI ambitions - AD HOC NEWS
IQVIA Signals Confidence with $3.2 Billion Share Repurchase War Chest - BriefGlance
IQVIA (IQV) Fell Despite Strong Fundamentals - Insider Monkey
IQVIA Holdings, Inc. (IQV) Stock Analysis: Growth Potential and Analyst Consensus Point to 35% Upside - DirectorsTalk Interviews
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):